Tirzepatide is approved for 3 indications in the US: type 2 diabetes, chronic weight management, and obstructive sleep apnea.

Scientists explored selectively blocking the CYP3A4 protein responsible for breaking down large swaths of approved drugs, providing a way to improve drug efficacy.

Pathogenic Salmonella injects effector proteins into the cells of the gastrointestinal tract to penetrate and multiply within ...

HURA READ THE FULL HURA RESEARCH REPORT Operational and Financial Results On April 1st, 2025, TuHURA Biosciences, Inc.

Clinicians should be vigilant about cardiovascular side effects with ADHD medications but not avoid using them, experts say.

Investigational tolebrutinib slowed disability progression in people with non-relapsing secondary progressive multiple ...

If you believe you or a loved one is experiencing depression, here's what mental health experts want you to know about ...

Recursion Pharmaceuticals' stock is soaring today on news the FDA is planning on phasing out some animal testing, replacing ...

A new research perspective was published in , Volume 16, on April 4, 2025, titled "GSK3β activation is a key driver of ...

Carnegie Mellon University’s Summer Undergraduate Research Fellowship (SURF) program provides funding for undergraduates to work full time on research projects during the summer. Many students ...

As obesity rates rise among individuals with T1D, GLP-1 agonist medications, indicated for T2D and weight loss, are ...

Americans are being killed by drugs laced with fentanyl. But the good news is, naloxone, which can reverse fentanyl’s deathly effect, is now available for free in Georgia.